D Warot
Overview
Explore the profile of D Warot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Warot D, Berlin I, Aymard G, Ankri A, Fabry C, Besse B, et al.
Fundam Clin Pharmacol
. 2004 Dec;
14(3):231-6.
PMID: 15602800
Beraprost sodium (BPS), an orally active PGI2 (prostaglandine 12) analogue possesses vasodilatating and platelet aggregation inhibiting properties. It is being developed in peripheral arterial occlusive disease. As in future clinical...
2.
Marra D, Warot D, Berlin I, Hispard E, Dally S
Eur Psychiatry
. 2003 Dec;
18(8):415-7.
PMID: 14680719
We investigated plasma cortisol in a psychological stress paradigm in seven weaned anhedonic alcoholics in comparison with seven age-matched healthy controls. Alcoholics had significantly higher mean plasma cortisol at baseline...
3.
Aymard G, Warot D, Demolis P, Laville I, Diquet B
J Pharm Biomed Anal
. 2002 Nov;
30(4):1013-21.
PMID: 12408892
Nefopam (NEF) and desmethyl-nefopam (DMN) were assayed simultaneously in plasma, globule and urine samples using imipramine as internal standard. A liquid-liquid extraction procedure was coupled with a reverse phase high-performance...
4.
Berlin I, Warot D, Aymard G, Acquaviva E, Legrand M, Labarthe B, et al.
Eur J Clin Pharmacol
. 2001 Nov;
57(6-7):447-55.
PMID: 11699608
Objective: To determine the cardiovascular, subjective effects and potential of abuse liability of single dose (-) ephedrine (E) administered orally (50 mg) or intranasally (10 mg and 5 mg). Methods:...
5.
Lebrun-Vignes B, Archer V, Diquet B, Levron J, Chosidow O, Puech A, et al.
Br J Clin Pharmacol
. 2001 Jun;
51(5):443-50.
PMID: 11422002
Aims: Itraconazole is a potent inhibitor of CYP3A4 activity and is often used in combination with corticosteroids. Since the latter are partly metabolized by CYP3A4, we studied the interaction between...
6.
Aymard G, Labarthe B, Warot D, Berlin I, Diquet B
J Chromatogr B Biomed Sci Appl
. 2000 Sep;
744(1):25-31.
PMID: 10985563
A high-performance liquid chromatography procedure for the determination of ephedrine and norephedrine using fluorimetric detection in plasma samples is described. A double liquid-liquid extraction was performed, followed by derivatization with...
7.
Marra D, Warot D, Payan C, Hispard E, Dally S, Puech A
Psychiatry Res
. 1998 Oct;
80(2):187-96.
PMID: 9754698
The aim of this study was to determine the role of anhedonia among other psychopathological dimensions in the relapse of alcoholics 6 months after withdrawal. Psychometric assessments included: the Social...
8.
Berlin I, Warot D, Legout V, Guillemant S, Schollnhammer G, Puech A
Clin Pharmacol Ther
. 1998 May;
63(4):428-36.
PMID: 9585797
Objectives: To assess whether acute 5-hydroxytryptamine-1A (5-HT1A)-receptor-mediated corticotropin, cortisol, and temperature responses are maintained after 3 weeks of treatment with controlled-release (CR) ipsapirone and fluoxetine compared with placebo and whether...
9.
Warot D, Danjou P, Payan C, Puech A
Drug Alcohol Depend
. 1997 May;
45(3):177-83.
PMID: 9179519
The main metrological characteristics of a French version of the 49-item addiction research center inventory (ARCI) were evaluated using data collected in three controlled studies in healthy subjects. An analysis...
10.
Warot D, Berlin I, Patat A, Durrieu G, Zieleniuk I, Puech A
J Clin Pharmacol
. 1996 Oct;
36(10):942-50.
PMID: 8930782
Befloxatone is a new reversible and selective monoamine oxidase (MAO-A) inhibitor that has been shown to have antidepressant activity in various animal models. To assess the effects of single oral...